A UAB-led study finds that multiple myeloma returning within three years of intensive frontline treatment should be ...

Researchers have found that with new treatments for multiple myeloma, a serious type of blood cancer, clinicians should use ...

Australian researchers have found a new biomarker for multiple myeloma that could help doctors rapidly identify patients at ...

In the era of combination quadruplet therapy (QUAD) + autologous stem cell transplantation (ASCT), functional high-risk (FHR) ...

For patients with newly diagnosed multiple myeloma not undergoing an autologous stem cell transplant, indefinite lenalidomide maintenance has long been standard care despite limited evidence to guide ...

Data show that patients’ multiple myeloma still fails to progress if patients receive less-frequent Tecvayli. A reduced dosing schedule of Tecvayli (teclistamab) continued to slow the progression of ...

May 29 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab said on Friday that its experimental oral drug mezigdomide delayed disease progression in a late-stage trial of multiple myeloma patients ...

When the BBC presenter Lauren Laverne revealed she has smoldering myeloma, the diagnosis sounded more alarming than it is.

Multiple myeloma is a relatively uncommon cancer of plasma cells, where excessive proliferation of these malignant cells within the bone marrow leads to abnormal antibody production. The disease ...

Lauren Laverne’s diagnosis has put smouldering myeloma in the spotlight – a blood condition doctors watch closely but don’t ...